【联合国新闻非洲·刚果】Ebola vaccine trial begins in DR Congo

aipl1234

#刚果

Ebola vaccine trial begins in DR Congo



原文原文 / Original Text

© WFP/Benjamin Anguandia A WFP worker speaks to women preparing food for people affected by Ebola in Goma, capital of DRC's North Kivu Province. Facebook Twitter Print Email

An Ebola vaccine trial is underway in the Democratic Republic of the Congo (DRC), involving frontline health workers and others involved in the response.

The UN World Health Organization (WHO) said on Monday that 20,000 doses of the Ervebo vaccine have been allocated for the research vaccination programme in Ituri province.

The aim of the trial is to improve understanding of how effective the vaccine is against Ebola Bundibugyo virus – and to protect individuals most exposed to it. 

The Ervebo vaccine has been “highly effective” against Ebola Zaire virus in the past, but it is not yet known whether it can provide “meaningful protection” against Ebola Bundibugyo disease, which is still spreading in the DRC.

A total of 70,000 doses have been made available to the Congolese authorities to support the outbreak response and related research.

The epicentre of the outbreak remains Ituri province in eastern DR Congo, although the virus has spread to seven provinces since it was confirmed in May this year.

Those leading the outbreak response face many challenges related to an ongoing humanitarian emergency caused by decades of violence in the DRC’s vast, resource-rich eastern provinces. 

本文为英文资讯，中文内容由机器翻译生成，仅供参考。详情请阅读文末原文。

—— 资讯转载说明 ——
本文由非洲论坛根据公开信息整理，供中国读者查阅，不代表本站立场。
来源：UN News Africa (https://news.un.org/en/news/region/africa)
原文链接：https://news.un.org/feed/view/en/story/2026/09/1168381
转载请遵守原发布方版权与引用规定。